Hims & Hers Health Inc [NYSE: HIMS] traded at a high on 2025-06-20, posting a 42237080 gain after which it closed the day’ session at $40040000.0.
The results of the trading session contributed to over 42237080 shares changing hands. Over the past one week, the price volatility of Hims & Hers Health Inc stands at 3.54% while the volatility over the past one month is 4.13%.
The market cap for HIMS stock reached $14.37 billion, with 215.21 million shares outstanding and 190.51 million shares in the current float. Compared to the average trading volume of 40.04M shares, HIMS reached a trading volume of 42237080 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Hims & Hers Health Inc [HIMS]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HIMS shares is $47.83 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HIMS stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Hims & Hers Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 04, 2025. The new note on the price target was released on April 29, 2025, representing the official price target for Hims & Hers Health Inc stock. Previously, the target price had yet another raise from $42 to $60, while Morgan Stanley kept a Equal-Weight rating on HIMS stock. On January 10, 2025, analysts increased their price target for HIMS shares from 24 to 25.
The Price to Book ratio for the last quarter was 26.14, with the Price to Cash per share for the same quarter was set at 1.44. Price to Free Cash Flow for HIMS in the course of the last twelve months was 61.10 with Quick ratio for the last quarter at 1.32.
How has HIMS stock performed recently?
Hims & Hers Health Inc [HIMS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 12.37. With this latest performance, HIMS shares gained by 4.92% in over the last four-week period, additionally plugging by 105.50% over the last 6 months – not to mention a rise of 165.59% in the past year of trading.
Hims & Hers Health Inc [HIMS]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Hims & Hers Health Inc [HIMS] shares currently have an operating margin of 6.48% and a Gross Margin at 68.19%. Hims & Hers Health Inc’s Net Margin is presently recorded at 9.21%.
Return on Equity for this stock inclined to 24.54%, with Return on Assets sitting at 24.54%.
Earnings analysis for Hims & Hers Health Inc [HIMS]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HIMS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Hims & Hers Health Inc go to 34.58%.
Insider trade positions for Hims & Hers Health Inc [HIMS]
There are presently around $74.65%, or 84.01%% of HIMS stock, in the hands of institutional investors. The top three institutional holders of HIMS stocks are: VANGUARD GROUP INC with ownership of 16.47 million shares, which is approximately 7.6746%. BLACKROCK INC., holding 14.57 million shares of the stock with an approximate value of $$294.25 million in HIMS stocks shares; and BLACKROCK INC., currently with $$121.94 million in HIMS stock with ownership which is approximately 2.814%.
